Elite Pharmaceuticals, Inc. Deferred Tax Liabilities, Net
Elite Pharmaceuticals, Inc. (ELTP) had Deferred Tax Liabilities, Net of $22.16 million as of 2024-03-31, per its 10-K filed 2024-07-01.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilities · last filed 2024-07-01
- 2024-03-31: Deferred Tax Liabilities, Net $22.16M.
- 2023-03-31: Deferred Tax Liabilities, Net $2.17M.
| Period end | Deferred Tax Liabilities, Net |
|---|---|
| 2024-03-31 | $22.16M 10-K · filed 2024-07-01 |
| 2023-03-31 | $2.17M 10-K · filed 2024-07-01 |